{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T22:24:25Z","timestamp":1776896665952,"version":"3.51.2"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,5]]},"DOI":"10.7759\/cureus.11342","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T13:31:54Z","timestamp":1604583114000},"source":"Crossref","is-referenced-by-count":5,"title":["A Rare, Unreported Cognitive Side Effect of Topiramate: Do We Know It All Yet?"],"prefix":"10.7759","author":[{"given":"Nurose","family":"Karim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajaz A","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/bs.podrm.2018.11.005","article-title":"Topiramate: comprehensive profile","volume":"44","author":"Khalil NY","year":"2019","unstructured":"Khalil NY, AlRabiah HK, Al Rashoud SS, Bari A, Wani TA. Topiramate: comprehensive profile. Profiles Drug Subst Excip Relat Methodol. 2019, 44:333-378. 10.1016\/bs.podrm.2018.11.005","journal-title":"Profiles Drug Subst Excip Relat Methodol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.2000.tb02175.x","article-title":"Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults","volume":"41","author":"Reife R","year":"2000","unstructured":"Reife R, Pledger G, Wu SC. Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults. Epilepsia. 2000, 41:66-71. 10.1111\/j.1528-1157.2000.tb02175.x","journal-title":"Epilepsia"},{"key":"ref3","article-title":"Comparative neurocognitive effects of 5 psychotropic anticonvulsants and lithium","volume":"8","author":"Gualtieri CT","year":"2006","unstructured":"Gualtieri CT, Johnson LG. Comparative neurocognitive effects of 5 psychotropic anticonvulsants and lithium. MedGenMed. 2006, 8:46.","journal-title":"MedGenMed"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2009.10.001","article-title":"Cognitive effects of topiramate in migraine patients aged 12 through 17 years","volume":"42","author":"Pandina GJ","year":"2010","unstructured":"Pandina GJ, Ness S, Polverejan E, Yuen E, Eerdekens M, Bilder RM, Ford L. Cognitive effects of topiramate in migraine patients aged 12 through 17 years. Pediatr Neurol. 2010, 42:187-195. 10.1016\/j.pediatrneurol.2009.10.001","journal-title":"Pediatr Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003736","article-title":"Effect of topiramate and zonisamide on fMRI cognitive networks","volume":"88","author":"Wandschneider B","year":"2017","unstructured":"Wandschneider B, Burdett J, Townsend L, Hill A, Thompson PJ, Duncan JS, Koepp MJ. Effect of topiramate and zonisamide on fMRI cognitive networks. Neurology. 2017, 88:1165-1171. 10.1212\/WNL.0000000000003736","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.2000.tb00322.x","article-title":"A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures","volume":"41","author":"Aldenkamp AP","year":"2000","unstructured":"Aldenkamp AP, Baker G, Mulder OG, et al.. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures. Epilepsia. 2000, 41:1167-1178. 10.1111\/j.1528-1157.2000.tb00322.x","journal-title":"Epilepsia"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2004.06.017","article-title":"Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication","volume":"5","author":"Kockelmann E","year":"2004","unstructured":"Kockelmann E, Elger CE, Helmstaedter C. Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication. Epilepsy Behav. 2004, 5:716-721. 10.1016\/j.yebeh.2004.06.017","journal-title":"Epilepsy Behav"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2001.41700.x","article-title":"Postmarketing experience with topiramate and cognition","volume":"42","author":"Tatum WO IV","year":"2001","unstructured":"Tatum WO IV, French JA, Faught E, et al.. Postmarketing experience with topiramate and cognition. Epilepsia. 2001, 42:1134-1140. 10.1046\/j.1528-1157.2001.41700.x","journal-title":"Epilepsia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2008.10.017","article-title":"Patient-reported cognitive side effects of antiepileptic drugs: predictors and comparison of all commonly used antiepileptic drugs","volume":"14","author":"Arif H","year":"2009","unstructured":"Arif H, Buchsbaum R, Weintraub D, Pierro J, Resor SR Jr, Hirsch LJ. Patient-reported cognitive side effects of antiepileptic drugs: predictors and comparison of all commonly used antiepileptic drugs. Epilepsy Behav. 2009, 14:202-209. 10.1016\/j.yebeh.2008.10.017","journal-title":"Epilepsy Behav"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-282x2002000200019","article-title":"Acute psychotic disorders induced by topiramate: report of two cases","volume":"60","author":"Stella F","year":"2002","unstructured":"Stella F, Caetano D, Cendes F, Guerreiro CA. Acute psychotic disorders induced by topiramate: report of two cases. Arq Neuropsiquiatr. 2002, 60:285-287. 10.1590\/s0004-282x2002000200019","journal-title":"Arq Neuropsiquiatr"},{"key":"ref11","article-title":"Substance-induced dissociative disorders and psychiatric nosology","volume":"9","author":"Good MI","year":"1989","unstructured":"Good MI. Substance-induced dissociative disorders and psychiatric nosology. J Clin Psychopharmacol. 1989, 9:88-93.","journal-title":"J Clin Psychopharmacol"},{"key":"ref12","article-title":"Substance Abuse Treatment for Persons With Co-Occurring Disorders","author":"Substance Abuse and Mental Health Services Administration (US)","year":"2005","unstructured":"Substance Abuse and Mental Health Services Administration (US). Substance Abuse Treatment for Persons With Co-Occurring Disorders. Center for Substance Abuse Treatment, Rockville; 2005."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.125192","article-title":"A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions","volume":"46","author":"Belhekar MN","year":"2014","unstructured":"Belhekar MN, Taur SR, Munshi RP. A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions. Indian J Pharmacol. 2014, 46:117-120. 10.4103\/0253-7613.125192","journal-title":"Indian J Pharmacol"},{"key":"ref14","article-title":"Topiramate-induced dissociative disorder","volume":"8","author":"Sarwar SR","year":"2011","unstructured":"Sarwar SR, McGinnis RA. Topiramate-induced dissociative disorder. Innov Clin Neurosci. 2011, 8:14-16.","journal-title":"Innov Clin Neurosci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2008.05.007","article-title":"Topiramate effects on plasma serotonin levels in children with epilepsy","volume":"81","author":"Grosso S","year":"2008","unstructured":"Grosso S, Blardi P, Battaglini M, Franzoni E, De Lalla A, Mostardini R, Balestri P. Topiramate effects on plasma serotonin levels in children with epilepsy. Epilepsy Res. 2008, 81:148-154. 10.1016\/j.eplepsyres.2008.05.007","journal-title":"Epilepsy Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/45076-a-rare-unreported-cognitive-side-effect-of-topiramate-do-we-know-it-all-yet","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:29:27Z","timestamp":1707506967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/45076-a-rare-unreported-cognitive-side-effect-of-topiramate-do-we-know-it-all-yet"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.11342","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,5]]}}}